Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vestn Otorinolaringol ; (6): 48-50, 2012.
Article in Russian | MEDLINE | ID: mdl-23268248

ABSTRACT

The objective of the present study was to improve the efficacy of the treatment of the patients presenting with atrophic rhinitis (ozena) of the upper respiratory tract by the application of helium-neon laser radiation. A total of 120 patients aged from 15 to 53 years were treated based at the Department of Otorhinolaryngology, G.G. Kuvatov Republican Clinical Hospital, Ufa. All these patients underwent routine clinical, roentgenological, microbiological, and rheographic examination. The method for the treatment of atrophic rhinitis is described; it includes the application of helium-neon laser radiation in combination with the administration of the purified preparation of liquid polyvalent Klebsiella bacteriophage. The positive results of the treatment by the proposed method were documented in 90% of the patients.


Subject(s)
Lasers, Gas/therapeutic use , Low-Level Light Therapy/instrumentation , Rhinitis, Atrophic/radiotherapy , Adolescent , Adult , Follow-Up Studies , Humans , Middle Aged , Treatment Outcome , Young Adult
2.
Vestn Otorinolaringol ; (6): 51-2, 2012.
Article in Russian | MEDLINE | ID: mdl-23268249

ABSTRACT

The objective of the present work was to study specific immunogenetic characteristics of 1-beta interleukin (IL 1-beta) production and estimate the possibility of using recombinant IL 1-beta for the treatment of recurrent suppurative rhinosinusitis. It was shown that the low production of IL 1-beta attributable to the combination of genotypes +3953>T *C/*C and -511C>T *C/*TAND *t/*t is associated with a relapse of suppurative rhinosinusitis. The patients presenting with this disorder are in need of dispensary examination and repeated administration of recombinant IL 1 beta (betaleukin) during the period of exacerbation of suppurative rhinosinusitis.


Subject(s)
Interleukin-1beta/metabolism , Interleukin-1beta/therapeutic use , Rhinitis/drug therapy , Sinusitis/drug therapy , Chronic Disease , Genotype , Humans , Interleukin-1beta/genetics , Prognosis , Recombinant Proteins , Recurrence , Rhinitis/genetics , Rhinitis/metabolism , Sinusitis/genetics , Sinusitis/metabolism , Suppuration/drug therapy , Suppuration/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...